Skip to content
Search

Latest Stories

Margin delivery rate increases from October

The Pharmaceutical Services Negotiating Committee (PSNC) has announced that the margin delivery rates will increase from October as the agreed £100m write-off is implemented.

“The baseline margin allowance will remain £800m per year in 2022/23 and 2023/24,” said the PSNC.


“Margin levels in the last two full years (2020/21 and 2021/22), as measured by the Margin Survey of independent pharmacies, were in excess of the baseline allowance, meaning that an excess was accrued.”

It also added: “In October 2022 there will be a modest uplift to Drug Tariff prices, and further uplifts will also be enacted in subsequent Drug Tariffs in 2022/23 and 2023/24 (subject to forecasts of pharmacy contractor margin retention levels being accurate).”

The Single Activity Fee (SAF) will stay set at £1.27 as enter the second half of 2022/23. However, the SAF may be subject to change later in 2022/23 or in 2023/24, depending on prescription volume expectations and overall fee delivery rates.

Transitional Payments were originally scheduled to end in March 2021 but PSNC has successfully negotiated for their extension in subsequent years.

As new services have been introduced and take up of these has accelerated, the amount of unallocated funding left in the CPCF is now less than it previously was. As such, the value of the Transitional Payments will decrease from its current level. Some of the unallocated funding remaining in 2023/24 will be repurposed into a Flat Payment for all contractors (see details below).

Over the course of the second half of 2022/23, the value of the Transitional Payments will be phased down. This will start in October 2022 with a reduction in payment levels to approximately 85% of the current level, as shown in the following table:

Number of items per month from 1 October 2022Monthly Dispensing Payment of the Transitional Payment from 1 October 2022Monthly Service Payment of the Transitional Payment from October 2022
0 – 100£0£0
101 – 2,500£51.55£51.55
2,501 – 5,000£600.60£600.60
5,001 – 12,500£757.84£757.84
12,501 – 19,167£821.42£821.42
19,168+£853.22£853.22

Further significant reductions will also be needed before March 2023. Funding delivery levels will be monitored on a month-by-month basis by PSNC and DHSC, in order to determine the appropriate level for the Transitional Payments as we approach March 2023.

In addition to the reduction in the value of the Transitional Payments, there will also be an increase in the proportion of these payments linked to service delivery. From November 2022, the ‘service element’ of the Transitional Payment will make up 75% of the value of the Transitional Payment.

From April 2023, a new flat payment will be made to all contractors dispensing at least 101 items per month. The total funding allocation for the flat payment will be £70m annually.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less